Anti-osteoporosis agent-8
Product Specifications
Target
RANKL/RANK, NF-κB, p38 MAPK
Related Pathways
MAPK, NF-κB
Bioactivity
Anti-osteoporosis agent-8 (Compound 4aa) is a RANKL inhibitor, capable of preventing RANKL-induced osteoclastogenesis and osteoclast differentiation, with an IC50 of 2.41 μM. Furthermore, Anti-osteoporosis agent-8 has been shown to mitigate bone loss in an ovariectomized (OVX) mouse model.
Molecular Formula
C18H19F3N2O2Se
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL305051V 500 µL Each
DECR2 Human shRNA Lentiviral Particle (Locus ID 26063)
Sign In for Pricing
View Details 
SIPB391Mu02-01 10 µg
Recombinant Macrophage Stimulating Protein (MSP)
Sign In for Pricing
View Details SIPB391Mu02-02 50 µg
Recombinant Macrophage Stimulating Protein (MSP)
Sign In for Pricing
View Details SIPB391Mu02-03 200 µg
Recombinant Macrophage Stimulating Protein (MSP)
Sign In for Pricing
View Details